Bill Gates, who decided to invest $100 million in Alzheimer’s disease research in 2017 and revealed earlier this year that his father was affected by the disease, is now directing some of that commitment to developing a diagnostic test. Such a test would help the 14 million people expected to be affected by the brain disorder in the U.S. by 2050 with the chance to come to terms with their condition, and perhaps, if new treatments are developed, even take advantage of these therapies as early as possible.
Gates announced that he is committing more than $30 million to the Diagnostics Accelerator, a project with the Alzheimer’s Drug Discovery Foundation (ADDF), that will focus on creating new strategies for diagnosing the disease. Gates is joined by Leonard Lauder, co-founder of the Alzheimer’s Drug Discover Foundation, the Dolby Family and the Charles and Helen Schwab Foundation among others in the effort.
To read the full article go to: http://time.com/5341036/bill-gates-alzheimers-disease-research/